Skip to main content

Table 1 Baseline characteristics. N = 598

From: Is Frailty Index a better predictor than pre-stroke modified Rankin Scale for neurocognitive outcomes 3-months post-stroke?

Demographics

  Mean/SD age, years

71.6/11.9

  Female sexa

257 (43.0)

  Mean/SD education, years

12.5/3.8

  Mean/SD pre-stroke mRSb

0.8/1.0

  Mean/SD GDS pre-strokec

1.4/0.8

TOAST classificationd

  Large-vessel disease

54 (10.2)

  Cardioembolic disease

123 (23.3)

  Small-vessel disease

120 (22.7)

  Other etiology

14 (2.7)

  Undetermined etiology

217 (41.1)

Assessments

  Mean/SD NIHSS (0–42) day 1e

3 /4

  Mean/SD mRS at admittancef

2.06 /1.3

Mean/SD Frailty Index baseline

0.14/0.10

  Frailty Grade

    Robust

140 (23.4)

    Pre-frail

367 (61.4)

    Frail

91 (15.2)

Complications in the acute phase

  Acute stroke progressiong

42 (7.3)

  Infection treated with antibioticsh

63 (10.6)

MRI findings acute phasei

 Fazekas pathologyj

118 (34.1)

 MTA pathologyk

112 (32.4)

  1. SD Standard deviation, mRS modified Rankin Scale, TOAST Trial of Org 10,172 in Acute Stroke Treatment, NIHSS National Institutes of Health Stroke Scale, MRI Magnetic resonance imaging, MTA Medial Temporal Atrophia
  2. anumbers are n (%), unless otherwise specified
  3. bN = 597
  4. cN = 595
  5. dN = 528
  6. eN = 588
  7. fN = 596 576
  8. gN = 576 594
  9. hN = 594 346
  10. i346
  11. jFazekas pathology were rated according to the Fazekas scale[16]
  12. kMTA was rated according to the Scheltens scale [17]